Investigation of Blood Betatrophin Levels in Obese Children with Non-Alcoholic Fatty Liver Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The prevalence of obesity has significantly increased among children and adolescents worldwide and is becoming an important health care problem in parallel with the increased prevalence of obesity pediatric non-alco-holic fatty liver disease. Betatrophin is a newly define hormone that is commonly secreted by liver and plays role in glucose tolerance. This study aimed to investigate the relationship between serum betatrophin levels and non-alco-holic fatty liver disease in obese children.Methods: The study included 40 obese children with a body mass index (BMI) above 95th centile, and 35 non-obese subjects with a BMI 3-85th centile, whose age and gender were similar to those of the patient group. For the evaluation of metabolic parameters fasting serum glucose, insulin, alanine aminotransferase, aspartate aminotransferase, lipid profile and serum betatrophin levels were measured. Total cholesterol: high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratios were calculated as “atherogenicindices.”Results: Serum betatrophin levels of the obese subjects were similar to that of non-obese subjects (p=0.90). Betatrophin levels were not correlated with the metabolic parameters.Conclusion: In the present study, levels of betatrophin are not different between obese and insulin resistant children and non-obese subjects, and they are not correlated with atherogenic indices. To elucidate the exact role of beta-trophin in obesity, further studies are required to identify the betatrophin receptor and/or other possible cofactors.
Abstract
Purpose: The prevalence of obesity has significantly increased among children and adolescents worldwide and is becoming an important health care problem in parallel with the increased prevalence of obesity pediatric non-alco-holic fatty liver disease. Betatrophin is a newly define hormone that is commonly secreted by liver and plays role in glucose tolerance. This study aimed to investigate the relationship between serum betatrophin levels and non-alco-holic fatty liver disease in obese children.Methods: The study included 40 obese children with a body mass index (BMI) above 95th centile, and 35 non-obese subjects with a BMI 3-85th centile, whose age and gender were similar to those of the patient group. For the evaluation of metabolic parameters fasting serum glucose, insulin, alanine aminotransferase, aspartate aminotransferase, lipid profile and serum betatrophin levels were measured. Total cholesterol: high-density lipoprotein cholesterol and low-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratios were calculated as “atherogenicindices.”Results: Serum betatrophin levels of the obese subjects were similar to that of non-obese subjects (p=0.90). Betatrophin levels were not correlated with the metabolic parameters.Conclusion: In the present study, levels of betatrophin are not different between obese and insulin resistant children and non-obese subjects, and they are not correlated with atherogenic indices. To elucidate the exact role of beta-trophin in obesity, further studies are required to identify the betatrophin receptor and/or other possible cofactors.
참고문헌 (25)
- Schwimmer JB, "Prevalence of fatty liver in children and adolescents", Pediatrics, 118, pp.1388~1393 (2006)[DOI]
- Takahashi Y, "Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology", World J Gastroenterol, 16, pp.5280~5285 (2010)[DOI]
- Wong RJ, "Obesity and non-alcoholic fatty liver disease: disparate associations among Asian populations", World J Hepatol, 6, pp.263~273 (2014)[DOI]
- Tominaga K, "Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey", Dig Dis Sci, 40, pp.2002~2009 (1995)[DOI]
- Liu L, "Roles of chronic low-grade inflammation in the development of ectopic fat deposition", Mediators Inflamm (2014)
- Nguyen P, "Liver lipid metabolism", J Anim Physiol Anim Nutr (Berl), 92, pp.272~283 (2008)[DOI]
- Marzuillo P, "Pediatric non-alcoholic fatty liver disease: new insights and future directions", World J Hepatol, 6, pp.217~225 (2014)[DOI]
- Dali-Youcef N, "Metabolic inflammation: connecting obesity and insulin resistance", Ann Med, 45, pp.242~253 (2013)[DOI]
- Wellen KE, "Obesity-induced inflammatory changes in adipose tissue", J Clin Invest, 112, pp.1785~1788 (2003)[DOI]
- Fu Z, "Elevated circulating lipasin", betatrophin in human type 2 diabetes and obesity, 2014, pp.4, 5013~
- Gomez-Ambrosi J, "Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes", J Clin Endocrinol Metab, 99, pp.E2004~E2009 (2014)[DOI]
- Wang Y, "Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis", Proc Natl Acad Sci U S A, 110, pp.16109~16114 (2013)[DOI]
- Wu S, "Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance", Pediatr Diabetes, 17, pp.53~60 (2016)[DOI]
- Ozturk A, "Reference body mass index curves for Turkish children 6 to 18 years of age", J Pediatr Endocrinol Metab, 21, pp.827~836 (2008)
- Valerio G, "Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy", Nutr Metab Cardiovasc Dis, 16, pp.279~284 (2006)[DOI]
- Singh D, "Imaging of non alcoholic fatty liver disease: a road less travelled", Indian J Endocrinol Metab, 17, pp.990~995 (2013)[DOI]
- Vos MB, "NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)", J Pediatr Gastroenterol Nutr, 64, pp.319~334 (2017)[DOI]
- Fenzl A, "Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals", Diabetologia, 57, pp.1204~1208 (2014)[DOI]
- Hu H, "Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients", Diabetes Care, 37, pp.2718~2722 (2014)[DOI]
- Abu-Farha M, "Higher plasma betatrophin", ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance, 2015, pp.5, 10949~
- Calan M, "Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome", Endocrine, 53, pp.271~279 (2016)[DOI]
- Zhang R, "Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels", Biochem Biophys Res Commun, 424, pp.786~792 (2012)[DOI]
- Quagliarini F, "Atypical angiopoietin-like protein that regulates ANGPTL3", Proc Natl Acad Sci U S A, 109, pp.19751~19756 (2012)[DOI]
- Gao T, "Circulating betatrophin correlates with triglycerides and postprandial glucose among different glucose tolerance statuses--a case-control study", PLoS One, 10, pp.e0133640~ (2015)[DOI]
- Chen X, "Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance", J Clin Endocrinol Metab, 100, pp.E96~E100 (2015)[DOI]